BLISSGVS : UK SUBSIDIARY GETS MHRA MARKETING AUTHORISATION FOR MESALAZINE 1G SUPPOSITORIES

• Marketing authorisation granted by UK's MHRA to Asterisk Lifesciences Ltd, UK, a wholly owned subsidiary of Bliss GVS Pharma • Authorisation covers Mesalazine 1g Suppositories • Company intimated the grant under Regulation 30 of SEBI LODR Regulations, 2015 • No deal value, order value or revenue contribution disclosed in the filing

Bliss GVS Pharma Ltd

Open attachment

← Back to feed